The Dietary Approaches to Stop Hypertension (DASH) Eating Pattern in Special Populations

被引:0
作者
Crystal C. Tyson
Chinazo Nwankwo
Pao-Hwa Lin
Laura P. Svetkey
机构
[1] Duke University Medical Center,Division of Nephrology, Department of Medicine
[2] Duke University Medical Center,Sarah W. Stedman Nutrition and Metabolism Center
[3] Duke University Medical Center,Duke Hypertension Center
来源
Current Hypertension Reports | 2012年 / 14卷
关键词
Hypertension; Prehypertention; Stage I hypertension; Blood pressure; BP; Diet; Nutrition therapy; Lifestyle interventions; Medication therapy; Combination therapy; Chronic kidney disease; CKD; Diabetes mellitus; DM; Cardiovascular disease; CVD; Renin-angiotensin-aldosterone system inhibitors; RAAS inhibitors;
D O I
暂无
中图分类号
学科分类号
摘要
The Dietary Approaches to Stop Hypertension (DASH) trial showed that a diet rich in fruits, vegetables, low-fat dairy products with reduced total and saturated fat, cholesterol, and sugar-sweetened products effectively lowers blood pressure in individuals with prehypertension and stage I hypertension. Limited evidence is available on the safety and efficacy of the DASH eating pattern in special patient populations that were excluded from the trial. Caution should be exercised before initiating the DASH diet in patients with chronic kidney disease, chronic liver disease, and those who are prescribed renin-angiotensin-aldosterone system antagonist, but these conditions are not strict contraindications to DASH. Modifications to the DASH diet may be necessary to facilitate its use in patients with chronic heart failure, uncontrolled diabetes mellitus type II, lactose intolerance, and celiac disease. In general, the DASH diet can be adopted by most patient populations and initiated simultaneously with medication therapy and other lifestyle interventions.
引用
收藏
页码:388 / 396
页数:8
相关论文
共 269 条
[61]  
Leip EP(2003)Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial JAMA 289 2083-72
[62]  
Evans JC(2009)Hypertension improvement project: randomized trial of quality improvement for physicians and lifestyle modification for patients Hypertension 54 1226-3
[63]  
O'Donnell CJ(2000)Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors Am J Nephrol 20 268-undefined
[64]  
Kannel WB(2012)Predictors of hyperkalemia and death in patients with cardiac and renal disease Am J Cardiol 109 1510-undefined
[65]  
Lewington S(undefined)undefined undefined undefined undefined-undefined
[66]  
Clarke R(undefined)undefined undefined undefined undefined-undefined
[67]  
Qizilbash N(undefined)undefined undefined undefined undefined-undefined
[68]  
Peto R(undefined)undefined undefined undefined undefined-undefined
[69]  
Collins R(undefined)undefined undefined undefined undefined-undefined
[70]  
Cooper R(undefined)undefined undefined undefined undefined-undefined